MULTIPLAN CORP (MPLN) Stock Fundamental Analysis
USA - NYSE:MPLN - US62548M2098 - Common Stock
23.15 USD
-0.36 (-1.53%)
23.15 USD
0 (0%)
Taking everything into account, MPLN scores 2 out of 10 in our fundamental rating. MPLN was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of MPLN have multiple concerns. MPLN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year MPLN has reported negative net income.
In the past year MPLN had a positive cash flow from operations.
In the past 5 years MPLN reported 4 times negative net income.
Each year in the past 5 years MPLN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -31.95%, MPLN is in line with its industry, outperforming 50.00% of the companies in the same industry.
The Return On Equity of MPLN (-1958.81%) is worse than 81.58% of its industry peers.
The Return On Invested Capital of MPLN (1.58%) is better than 76.32% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MPLN is below the industry average of 6.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.95% | ||
| ROE | -1958.81% | ||
| ROIC | 1.58% |
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
1.3 Margins
MPLN's Operating Margin of 10.63% is amongst the best of the industry. MPLN outperforms 92.11% of its industry peers.
MPLN's Operating Margin has declined in the last couple of years.
MPLN has a Gross Margin of 74.27%. This is amongst the best in the industry. MPLN outperforms 84.21% of its industry peers.
MPLN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.63% | ||
| PM (TTM) | N/A | ||
| GM | 74.27% |
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
2. Health
2.1 Basic Checks
MPLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MPLN has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, MPLN has less shares outstanding
Compared to 1 year ago, MPLN has a worse debt to assets ratio.
2.2 Solvency
MPLN has an Altman-Z score of -0.30. This is a bad value and indicates that MPLN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.30, MPLN perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
MPLN has a Debt/Equity ratio of 53.67. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 53.67, MPLN is not doing good in the industry: 81.58% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 53.67 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.3 |
ROIC/WACC0.25
WACC6.29%
2.3 Liquidity
A Current Ratio of 0.82 indicates that MPLN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.82, MPLN is doing worse than 76.32% of the companies in the same industry.
A Quick Ratio of 0.82 indicates that MPLN may have some problems paying its short term obligations.
MPLN has a Quick ratio of 0.82. This is in the lower half of the industry: MPLN underperforms 71.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
MPLN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1059.83%.
MPLN shows a decrease in Revenue. In the last year, the revenue decreased by -3.21%.
Measured over the past years, MPLN shows a decrease in Revenue. The Revenue has been decreasing by -1.09% on average per year.
EPS 1Y (TTM)-1059.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-327%
Revenue 1Y (TTM)-3.21%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%-4.9%
3.2 Future
The Earnings Per Share is expected to grow by 36.67% on average over the next years. This is a very strong growth
MPLN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.09% yearly.
EPS Next Y87.02%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.75%
Revenue Next 2Y2.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
MPLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MPLN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
94.74% of the companies in the same industry are more expensive than MPLN, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.19 |
4.3 Compensation for Growth
A more expensive valuation may be justified as MPLN's earnings are expected to grow with 36.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.67%
EPS Next 3YN/A
5. Dividend
5.1 Amount
MPLN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.15
-0.36 (-1.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners47.86%
Inst Owner Change0.1%
Ins Owners6%
Ins Owner Change0%
Market Cap375.03M
Revenue(TTM)930.62M
Net Income(TTM)-1645831000
Analysts77.78
Price Target13.94 (-39.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.46%
Min EPS beat(2)-73.58%
Max EPS beat(2)14.65%
EPS beat(4)2
Avg EPS beat(4)-370.31%
Min EPS beat(4)-1467.36%
Max EPS beat(4)45.02%
EPS beat(8)5
Avg EPS beat(8)-168.93%
EPS beat(12)6
Avg EPS beat(12)-282.74%
EPS beat(16)9
Avg EPS beat(16)-181.58%
Revenue beat(2)0
Avg Revenue beat(2)-3.09%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-2.88%
Revenue beat(4)0
Avg Revenue beat(4)-4.72%
Min Revenue beat(4)-6.88%
Max Revenue beat(4)-2.88%
Revenue beat(8)2
Avg Revenue beat(8)-2.62%
Revenue beat(12)3
Avg Revenue beat(12)-3.01%
Revenue beat(16)6
Avg Revenue beat(16)-1.99%
PT rev (1m)26.15%
PT rev (3m)24.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.98%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)2.01%
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)-0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.4 | ||
| P/FCF | N/A | ||
| P/OCF | 3.48 | ||
| P/B | 4.46 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.19 |
EPS(TTM)-69.59
EYN/A
EPS(NY)-9.03
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)6.64
OCFY28.7%
SpS57.45
BVpS5.19
TBVpS-280.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.95% | ||
| ROE | -1958.81% | ||
| ROCE | 2% | ||
| ROIC | 1.58% | ||
| ROICexc | 1.59% | ||
| ROICexgc | 26.88% | ||
| OM | 10.63% | ||
| PM (TTM) | N/A | ||
| GM | 74.27% | ||
| FCFM | N/A |
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
ROICexc(3y)2.48%
ROICexc(5y)N/A
ROICexgc(3y)66.67%
ROICexgc(5y)N/A
ROCE(3y)3.05%
ROCE(5y)N/A
ROICexgc growth 3Y-40.96%
ROICexgc growth 5Y-27.14%
ROICexc growth 3Y-26.84%
ROICexc growth 5Y-14.89%
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
F-Score3
Asset Turnover0.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 53.67 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.49 | ||
| Cap/Depr | 27.34% | ||
| Cap/Sales | 12.69% | ||
| Interest Coverage | 0.31 | ||
| Cash Conversion | 20.27% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | -0.3 |
F-Score3
WACC6.29%
ROIC/WACC0.25
Cap/Depr(3y)25.06%
Cap/Depr(5y)22.79%
Cap/Sales(3y)10.77%
Cap/Sales(5y)9.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1059.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-327%
EPS Next Y87.02%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.21%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%-4.9%
Revenue Next Year0.75%
Revenue Next 2Y2.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.76%
EBIT growth 3Y-37.5%
EBIT growth 5Y-23.25%
EBIT Next Year144.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-116.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.33%
OCF growth 3Y-35.69%
OCF growth 5Y-17.66%
MULTIPLAN CORP / MPLN FAQ
Can you provide the ChartMill fundamental rating for MULTIPLAN CORP?
ChartMill assigns a fundamental rating of 2 / 10 to MPLN.
What is the valuation status for MPLN stock?
ChartMill assigns a valuation rating of 2 / 10 to MULTIPLAN CORP (MPLN). This can be considered as Overvalued.
What is the profitability of MPLN stock?
MULTIPLAN CORP (MPLN) has a profitability rating of 3 / 10.
What is the financial health of MULTIPLAN CORP (MPLN) stock?
The financial health rating of MULTIPLAN CORP (MPLN) is 1 / 10.